Scientists uncover clues to Tamoxifen's inner workings in breast cancer
NCT ID NCT01027416
First seen Apr 22, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This study looked at how the breast cancer drug tamoxifen interacts with certain proteins inside tumor cells. Researchers studied 59 women with a common type of breast cancer to better understand why some tumors respond to tamoxifen and others do not. The goal is to use this knowledge to choose the best treatment for future patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
University of Chicago
Chicago, Illinois, 60601, United States
Conditions
Explore the condition pages connected to this study.